Title 42 › CHAPTER 7 — SOCIAL SECURITY › SUBCHAPTER XI — GENERAL PROVISIONS, PEER REVIEW, AND ADMINISTRATIVE SIMPLIFICATION › Part E — Price Negotiation Program To Lower Prices for Certain High-Priced Single Source Drugs › § 1320f–5
Requires the Secretary to set up rules and processes so the maximum fair price for a chosen drug is used before any other health plan payments, financial help, or discounts. The rules must let the government apply that price across different strengths and forms of the drug (not by package size or formulation), and must work for people in Medicare prescription drug plans (Part D), Medicare Advantage drug plans (MA–PD), and people covered under Medicare Part B (including MA plans). The Secretary must also create a negotiation and renegotiation process, a way for drug makers to send required information, and procedures to apply related rules in other parts of the law. The agency must share with the Treasury any information needed to determine the tax under Internal Revenue Code section 5000D, including dates when certain discount or rebate agreements end and when new ones begin for the coverage gap discount, manufacturer discount, and Medicaid rebate programs. The Secretary must watch whether manufacturers follow their agreement terms and must set up a way to report any violations.
Full Legal Text
The Public Health and Welfare, Source: USLM XML via OLRC
Legislative History
Reference
Citation
42 U.S.C. § 1320f–5
Title 42, The Public Health and Welfare
Last Updated
Sep 22, 2026
Release point: 119-110